1 The functional and anti-ischaemic effects of the phosphodiesterase (PDE)-inhibitors, amrinone, milrinone and levosimendan, a new agent combining PDE-inhibitory with calcium-sensitizing properties, were investigated in rabbit isolated hearts (Langendorff, constant pressure: 70 cmH2O, Tyrode solution, Ca2+ 1.8 mmol 1', 37°C). Anti-ischaemic effects were studied in electrically-driven hearts (200 beats min '). Acute regional ischaemia was induced by ligature of a branch of the circumflex coronary artery and quantified from epicardial NADH-fluorescence photography. 2 Cumulative concentration-response curves in spontaneously beating hearts in the presence of isoprenaline (10-1 M), showed a higher inotropic and coronary vasodilator potency for levosimendan (ECm: 7 X 1O-7M) compared to milrinone (ECm: 7.7 x 10-6 M) or amrinone (EC5: 2 x 10-M).Although the maximal coronary dilator activity was similar for the three agents, the maximal inotropic and chronotropic effects were lower for levosimendan than for amrinone or milrinone (P <0.05).3 In regionally ischaemic hearts, milrinone (10-5 M) or levosimendan (5 x 10-6 M) similarly enhanced the left ventricular pressure (+ 15-20%) (P<0.05) and the global coronary flow (+ 40-50%) (P <0.05). The epicardial NADH-fluorescence area was significantly diminished by milrinone or levosimendan (-20-30%) (P<0.05) and there was no significant difference between the anti-ischaemic effects of either agent (P>0.05). 4 It is concluded that amrinone and milrinone possess similar functional profiles in rabbit isolated hearts and a higher inotropic and chronotropic efficacy than levosimendan. At functionally equieffective concentrations, milrinone and levosimendan show similar anti-ischaemic effects, related to an improvement of myocardial perfusion. The calcium-sensitizing properties seem not to be relevant for cardioprotection by levosimendan at the concentration used.